Bio Impact Capital LLC Arcutis Biotherapeutics, Inc. Transaction History

Bio Impact Capital LLC

  • $611 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$10.23 - $17.14 $81,144 - $135,954
-7,932 Reduced 3.03%
254,137 $2.8 Million
Q4 2022

Feb 14, 2023
BUY
$13.96 - $20.4 $68,180 - $99,633
4,884 Added 1.9%
262,069 $3.88 Million
Q3 2022

Nov 14, 2022
SELL
$17.85 - $26.95 $23,472 - $35,439
-1,315 Reduced 0.51%
257,185 $4.92 Million
Q1 2022

May 13, 2022
BUY
$14.38 - $22.79 $3.72 Million - $5.89 Million
258,500 New
258,500 $4.98 Million

Others Institutions Holding ARQT

# of Institutions
172
Shares Held
126M
Call Options Held
498K
Put Options Held
1.64M
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email